Activation of the JAK-STAT Signaling Pathway after In Vitro Stimulation with IFNß in Multiple Sclerosis Patients According to the Therapeutic Response to IFNß

Interferon beta (IFNß) is a common treatment used for multiple sclerosis (MS) which acts through the activation of the JAK-STAT pathway. However, this therapy is not always effective and currently there are no reliable biomarkers to predict therapeutic response. We postulate that the heterogeneity i...

Descripción completa

Detalles Bibliográficos
Autores principales: Hurtado-Guerrero, Isaac, Pinto-Medel, Maria Jesús, Urbaneja, Patricia, Rodriguez- Bada, Jose Luis, León, Antonio, Guerrero, Miguel, Fernández, Óscar, Leyva, Laura, Oliver-Martos, Begoña
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5245989/
https://www.ncbi.nlm.nih.gov/pubmed/28103257
http://dx.doi.org/10.1371/journal.pone.0170031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5245989/
https://www.ncbi.nlm.nih.gov/pubmed/28103257
http://dx.doi.org/10.1371/journal.pone.0170031

Ejemplares similares